Doseloop Beta

Empagliflozin

medication

SGLT2 inhibitor (brand name: Jardiance) for type 2 diabetes. Shows cardiovascular and kidney protection benefits. Used in some longevity protocols.

Reported Benefits

No side effects tracked yet

No side effects have been reported by studies or users for this habit yet.

Research (2 studies)

RCT

Effect of Empagliflozin on Whole Body, Cardiac, and Renal Sympathetic Nervous Activity in Patients With Type 2 Diabetes Mellitus: A Randomized Clinical Trial

Journal of the American Heart Association • 2024

Not specified in available details

RCT

Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial.

ClinicalTrials.gov • 2024

Not specified

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 2
Researched benefits 2
Side effects noted 0